Selvita and Rottapharm Madaus sign drug discovery contract
This article was originally published in Scrip
Executive Summary
The private Polish biotech company Selvita and Rottapharm Madaus of Italy have signed a drug discovery contract, under which Selvita will deliver a selection of compounds with therapeutic potential in an indicated area.